Your browser doesn't support javascript.
loading
Severe Toxic Epidermal Necrolysis and Drug Reaction with Eosinophilia and Systemic Symptoms Overlap Syndrome Treated with Benralizumab: A Case Report.
Zeller, Felix K; Bader, Patrick R; Nägeli, Mirjam C; Buehler, Philipp K; Schuepbach, Reto A.
Afiliação
  • Zeller FK; Institut für Intensivmedizin, Universitätsspital Zürich, Zürich, Switzerland.
  • Bader PR; Institut für Intensivmedizin, Universitätsspital Zürich, Zürich, Switzerland.
  • Nägeli MC; Dermatologische Klinik, Universitätsspital Zürich, Zürich, Switzerland.
  • Buehler PK; Institut für Intensivmedizin, Universitätsspital Zürich, Zürich, Switzerland.
  • Schuepbach RA; Institut für Intensivmedizin, Universitätsspital Zürich, Zürich, Switzerland.
Case Rep Dermatol ; 14(2): 203-209, 2022.
Article em En | MEDLINE | ID: mdl-36158858
ABSTRACT
TEN/DRESS overlap syndrome can be difficult to diagnose, especially if it is masked by comorbidities in critically ill patients in intensive care units. The existing therapy for the two conditions is also a major challenge for the treating team. A possible alternative, especially for refractory cases, is benralizumab as an IL-5-receptor alpha-chain-specific humanized monoclonal antibody (IgG1k). We are able to show a successful treatment in this case report.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article